Core Scientific (CORZ) Invested Capital (2021 - 2026)

Core Scientific has disclosed Invested Capital across 6 years of filings, most recently posting $3.7 billion for Q2 2026.

• In Q2 2026, Invested Capital rose 2847.91% year-over-year to $3.7 billion; the TTM figure through Jun 2026 stood at $3.7 billion (up 2847.91% YoY), while the FY2025 annual figure was $97.6 million, down 33.72% from the prior year.
• Invested Capital came in at $3.7 billion for Q2 2026 at Core Scientific, up from $1.6 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $3.7 billion in Q2 2026 to a low of -$636.0 million in Q2 2024.
• Average Invested Capital over 5 years is $533.3 million, with a median of $179.4 million recorded in 2023.
• Year-over-year, Invested Capital surged 3060.53% in 2022 and slumped 185.86% in 2024.
• Over 5 years, Invested Capital stood at -$373.1 million in 2022, then surged by 156.69% to $211.5 million in 2023, then tumbled by 30.39% to $147.2 million in 2024, then sank by 33.72% to $97.6 million in 2025, then soared by 3681.52% to $3.7 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $3.7 billion in Q2 2026, $1.6 billion in Q1 2026, and $97.6 million in Q4 2025.